ustekinumab,guselkumab
biond biologics,janssen
['crohn', 'guselkumab', 'ustekinumab', 'ibd', 'biond ']
guselkumab in cd showed no dose-response relationship and may have marginal benefit over ustekinumab #aibd2022 
Gastroenterologist with focus on #IBD and quality improvement @utswnews (Tweets mine, not medical advice, of course)